FI990752A0 - Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä - Google Patents

Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Info

Publication number
FI990752A0
FI990752A0 FI990752A FI990752A FI990752A0 FI 990752 A0 FI990752 A0 FI 990752A0 FI 990752 A FI990752 A FI 990752A FI 990752 A FI990752 A FI 990752A FI 990752 A0 FI990752 A0 FI 990752A0
Authority
FI
Finland
Prior art keywords
physostigmine
preparation
carbamate derivatives
derivatives
carbamate
Prior art date
Application number
FI990752A
Other languages
English (en)
Swedish (sv)
Other versions
FI990752A (fi
Inventor
George E Lee
Thomas B K Lee
Donna M Borek
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Priority to FI990752A priority Critical patent/FI990752A/fi
Publication of FI990752A0 publication Critical patent/FI990752A0/fi
Publication of FI990752A publication Critical patent/FI990752A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI990752A 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä FI990752A (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI990752A FI990752A (fi) 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91871992A 1992-07-21 1992-07-21
FI933264A FI933264A (fi) 1992-07-21 1993-07-19 Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
FI990752A FI990752A (fi) 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Publications (2)

Publication Number Publication Date
FI990752A0 true FI990752A0 (fi) 1999-04-06
FI990752A FI990752A (fi) 1999-04-06

Family

ID=25440831

Family Applications (2)

Application Number Title Priority Date Filing Date
FI933264A FI933264A (fi) 1992-07-21 1993-07-19 Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
FI990752A FI990752A (fi) 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI933264A FI933264A (fi) 1992-07-21 1993-07-19 Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin

Country Status (16)

Country Link
US (1) US5498726A (fi)
JP (2) JP2899502B2 (fi)
KR (1) KR940005629A (fi)
CN (1) CN1037443C (fi)
AU (1) AU660550B2 (fi)
CA (1) CA2100908A1 (fi)
CZ (1) CZ284321B6 (fi)
FI (2) FI933264A (fi)
HU (1) HU212600B (fi)
IL (1) IL106419A (fi)
MX (1) MX9304397A (fi)
NO (1) NO301276B1 (fi)
NZ (1) NZ248180A (fi)
PH (1) PH30885A (fi)
RU (1) RU2116307C1 (fi)
TW (1) TW239143B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6495700B1 (en) * 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
TWI294718B (en) 2005-12-14 2008-03-11 Ind Tech Res Inst Frequency modulation-frequency shift keying (fm/fsk) demodulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US4900748A (en) * 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
NO932616L (no) 1994-01-24
JPH09176167A (ja) 1997-07-08
HUT65135A (en) 1994-04-28
US5498726A (en) 1996-03-12
NO301276B1 (no) 1997-10-06
FI990752A (fi) 1999-04-06
IL106419A (en) 1999-12-31
AU4204993A (en) 1994-01-27
JPH06179678A (ja) 1994-06-28
PH30885A (en) 1997-12-23
JP2949085B2 (ja) 1999-09-13
RU2116307C1 (ru) 1998-07-27
JP2899502B2 (ja) 1999-06-02
TW239143B (fi) 1995-01-21
IL106419A0 (en) 1993-11-15
NZ248180A (en) 1995-02-24
KR940005629A (ko) 1994-03-22
HU9302110D0 (en) 1993-11-29
NO932616D0 (no) 1993-07-20
CN1037443C (zh) 1998-02-18
MX9304397A (es) 1994-02-28
HU212600B (en) 1996-09-30
CZ284321B6 (cs) 1998-10-14
FI933264A0 (fi) 1993-07-19
AU660550B2 (en) 1995-06-29
CA2100908A1 (en) 1994-01-22
CZ147393A3 (en) 1994-03-16
CN1084174A (zh) 1994-03-23
FI933264A (fi) 1994-01-22

Similar Documents

Publication Publication Date Title
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO931346L (no) Fremgangsmaate for fremstilling av et bifenylderivat
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
NO305024B1 (no) FremgangsmÕte for fremstilling av piperidinderivater
NZ248179A (en) Process for the preparation of physostigmine carbamate derivatives
FI911420A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
FI990752A0 (fi) Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä
NO304883B1 (no) FremgangsmÕte ved fremstilling av hydrazin-nitroform
FI974027A0 (fi) Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi eseretoleista
FI943660A0 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
NO963084L (no) Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater
FI922518A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi
FI922519A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi
NO179446C (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser
IS4086A (is) Aðferð við framleiðslu efnasambanda
NO960854D0 (no) Fremgangsmåte for fremstilling av 9-amino-1,2,3,4-tetrahydroakridiner